System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Giorgio Grani is an expert in Endocrinology at Sapienza University of Rome (Italy). As of October 2026, ScienceLeadR ranks Giorgio Grani in the top 1% of experts worldwide for Thyroid Neoplasms and Endocrine Gland Neoplasms. Giorgio Grani has authored 172 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 546 (community average: 125). How the SLR is computed.

LeadR Profile

Giorgio Grani Sapienza University of Rome Italy
546 ScienceLeadR Reputation 546

Unlock

Register Login
Network Map

Endocrinology

Subspecialties: Surgery - Oncology - Medical Imaging

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2010 - 2026
Source: PubMed

Sapienza University of Rome

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 172

Citations

Citations: 4 606 1st author: 48 Last author: 15 Unique author: 13

Main journals

Endocrine 14
Clinical Thyroidology 13
J Clin Endocrinol Metab 12
Endocrine Abstracts 10
Thyroid 9

Best Journals

JAMA 1
Lancet Diabetes Endocrinol 1
Nat Rev Endocrinol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Beyond Surgical Follow-Up: Measuring the Long-Term Burden of Permanent Hypoparathyroidism After Thyroid Cancer Surgery.
PMID 42930569 — hypoparathyroidism, vitamins, neck dissection, neoplasms, thyroid gland, calcium, thyroid neoplasms, thyroidectomy, dissection		Med Sci (Basel)20260
The role of miR-335-5p in the redifferentiation of BRAF p.V600E thyroid cancers.
PMID 42325083 — cells, genes, neoplasms, thyroid gland, organoids, cell line, thyroid neoplasms, therapeutics, mutation		Mol Oncol20261
Real-world efficacy of Lenvatinib/Pembrolizumab combination in anaplastic thyroid carcinoma: case series from two Italian referral centers.
PMID 41973603 — thyroid diseases, thyroid gland, thyroid carcinoma, anaplastic, therapeutics		Eur Thyroid J20260
EFSUMB Guidelines on Multiparametric Ultrasound Thyroid Nodule Evaluation: PART I.
PMID 41330556 — diagnostic techniques and procedures, thyroid nodule, thyroid gland, biopsy, ultrasonics, artificial intelligence, needles		Ultraschall Med20250
EFSUMB Guidelines on Multiparametric Ultrasound Thyroid Nodule Evaluation: PART II.
PMID 41330557 — diagnostic techniques and procedures, thyroid nodule, thyroid gland, biopsy, ultrasonics, artificial intelligence, needles		Ultraschall Med20250

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 1

By status:

Recruiting 1

By type:

Observational 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 1

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS